On April 24, 2025, Alpha Tau Medical Ltd. entered into an agreement to sell 14,110,121 shares at $2.612 each, raising approximately $36.7 million, with the deal closing on April 28, 2025. The proceeds will support research and development, manufacturing expansion, and commercialization efforts.